C. David Nicholson - 03 Nov 2023 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role: Director
Signature: C. David Nicholson, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: ADVM
Transactions as of: 03 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Nov 2023, 19:54:40 UTC
Previous filing: 01 Jul 2022
Next filing: 29 Dec 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADVM	Stock Option (Right to Buy)	Award	$0	+80,000		$0.000000	80,000	03 Nov 2023	Common Stock	80,000	$0.9312	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of November 3, 2023 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Content

1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of November 3, 2023 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.